{
    "nctId": "NCT03176979",
    "briefTitle": "Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis For Patients With Newly Diagnosed Breast Cancer",
    "officialTitle": "Emerging Tools in the Detection of Breast Cancer: Comparison of Contrast Enhanced Spectral Mammography With Digital Breast Tomosynthesis to Conventional Imaging Techniques Including Contrast Enhanced Magnetic Resonance Imaging and 2D Mammography With or Without Targeted Ultrasound",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 43,
    "primaryOutcomeMeasure": "Index lesion size using the largest diameter",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Newly diagnosed breast cancer patients\n\nExclusion Criteria:\n\n* Women with history of surgical, medical, or radiation therapy for breast cancer\n* Women with renal failure or insufficiency\n* Women with iodine contrast allergy\n* Women with gadolinium contrast allergy\n* Women who are pregnant, possibly pregnant, or lactating\n* Women undergoing neoadjuvant chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}